Neuropeptide B (NPB) and neuropeptide W (NPW) system in cultured rat calvarial osteoblast-like (ROB) cells: NPWand NPB inhibit proliferative activity of ROB cells

International Journal of Molecular Medicine

Volumn 24, Issue 6, 2009, Pages 781-787

  Ziolkowska, Agneszka ^a   Rucinski, Marcin ^a   Tyczewska, Marianna ^a   Malendowicz, Ludwick K ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Neuropeptide B; Neuropeptide W; NPBWR1; Osteoblast like cell culture; Osteocalcin; Proliferation; Similar to NPBWR2

Indexed keywords

MESSENGER RNA; NEUROPEPTIDE; NEUROPEPTIDE B; NEUROPEPTIDE BW RECEPTOR 1; NEUROPEPTIDE BW RECEPTOR 2; NEUROPEPTIDE RECEPTOR; NEUROPEPTIDE W; OSTEOCALCIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CALVARIA; CELL ACTIVITY; CELL FUNCTION; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CELL GROWTH PROCESSES; CELLS, CULTURED; IMMUNOHISTOCHEMISTRY; NEUROPEPTIDES; OSTEOBLASTS; OSTEOCALCIN; POLYMERASE CHAIN REACTION; RATS; RATS, WISTAR; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE; SKULL;

EID: 70449432782     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000292     Document Type: Article

References (56)

1. O'Dowd BF, Scheideler MA, Nguyen T, Cheng R, Rasmussen JS, Marchese A, Zastawny R, Heng HH, Tsui LC, Shi X, Asa S, Puy L and George SR: The cloning and chromosomal mapping of two novel human opioid-somatostatin-like receptor genes, GPR7 and GPR8, expressed in discrete areas of the brain. Genomics 28: 84-91, 1995.
2. Lee DK, Nguyen T, Porter CA, Cheng R, George SR, Brian F and O'Dowd BF: Two related G protein-coupled receptors. The distribution of GPR7 in rat brain and the absence of GPR8 in rodents. Molec Brain Res 71: 96-103, 1999.
3. Fujii R, Yoshida H, Fukusumi S, Habata Y, Hosoya M, Kawamata Y, Yano T, Hinuma S, Kitada C, Asami T, Mori M, Fujisawa Y and Fujino M: Identification of a neuropeptide modified with bromine as an endogenous ligand for GPR7. J Biol Chem 277: 34010-34016, 2002.
4. Shimomura Y, Harada M, Goto M, Sugo T, Matsumoto Y, Abe M, Watanabe T, Asami T, Kitada Ch, Mori M, Onda H and Fujino M: Identification of neuropeptide W as the endogenous ligand for orphan G-protein-coupled receptors GPR7 and GPR8. J Biol Chem 277: 35826-35832, 2002.
5. Brezillon S, Lannoy V, Franssen JD, Le Poul E, Dupriez V, Lucchetti J, Detheux M and Parmentier M: Identification of natural ligands for the orphan G protein-coupled receptors GPR7 and GPR8. J Biol Chem 278: 776-783, 2003.
6. Tanaka H, Yoshida T, Miyamoto N, Motoike T, Kurosu H, Shibata K, Yamanaka A, Williams SC, Richardson JA, Tsujino N, Garry MG, Lerner MR, King DS, O'Dowd BF, Sakurai T and Yanagisawa M: Characterization of a family of endogenous neuropeptide ligands for the G protein-coupled receptors GPR7 and GPR8. Proc Natl Acad Sci USA 100: 6251-6256, 2003.
7. Mondal MS, Yamaguchi H, Date Y, Toshinai K, Kawagoe T, Tsuruta T, Kageyama H, Kawamura Y, Shioda S, Shimomura Y, Mori M and Nakazato M: Neuropeptide W is present in antral G cells of rat, mouse, and human stomach. J Endocrinol 188: 49-57, 2006.
8. Mondal MS, Yamaguchi H, Date Y, Tsuruta T, Shimbara T, Toshinai K, Shimomura Y, Mori M and Nakazato M: Ontogeny of a new enteric peptide, neuropeptide W (NPW), in the developing rat stomach. Regul Pept 145: 141-146, 2008.
9. Jackson VR, Lin SH, Wang Z, Nothacker HP and Civelli O: A study of the rat neuropeptide B/neuropeptide W system using in situ techniques. J Comp Neurol 497: 367-383, 2006.
10. Singh G and Davenport AP: Neuropeptide B and W: neuro-transmitters in an emerging G-protein-coupled receptor system. Br J Pharmacol 148: 1033-1041, 2006.
11. Schulz S, Stumm R and Höllt V: Immunofluorescent identification of neuropeptide B-containing nerve fibers and terminals in the rat hypothalamus. Neurosci Lett 411: 67-71, 2007.
12. Takenoya F, Kitamura S, Kageyama H, Nonaka N, Seki M, Itabashi K, Date Y, Nakazato M and Shioda S: Neuronal interactions between neuropeptide W- and orexin- or melanin-concentrating hormone-containing neurons in the rat hypothalamus. Regul Pept 145: 159-164, 2008.
13. Caminos JE, Bravo SB, García-Rendueles ME, Ruth González C, Garcés MF, Cepeda LA, Lage R, Suárez MA, López M and Diéguez C: Expression of neuropeptide W in rat stomach mucosa: Regulation by nutritional status, glucocorticoids and thyroid hormones. Regul Pept 146: 106-111, 2008.
14. Hondo M, Ishii M and Sakurai T: The NPB/NPW neuropeptide system and its role in regulating energy homeostasis, pain, and emotion. Results Probl Cell Differ 46: 239-256, 2008.
15. Ishii M, Fei H and Friedman JM: Targeted disruption of GPR7, the endogenous receptor for neuropeptides B and W, leads to metabolic defects and adult-onset obesity. Proc Natl Acad Sci USA 100: 10540-10545, 2003.
16. Mondal MS, Yamaguchi H, Date Y, Shimbara T, Toshinai Y, Shimomura Y, Mori M and Nakazato M: A Role for neuropeptide W in the regulation of feeding behavior. Endocrinology 144: 4729-4733, 2003.
17. Samson WK, Baker JR, Samson CK, Samson HW and Taylor MM: Central neuropeptide B administration activates stress hormone secretion and stimulates feeding in male rats. J Neuroendocrinol 16: 842-849, 2004.
18. Levine AS, Winsky-Sommerer R, Huintron-Resendiz S, Grace MK and de Lecea L: Injection of neuropeptide W into paraventicular nucleus of hypothalamus increases food intake. Am J Physiol Regul Integr Comp Physiol 288: 1727-1732, 2005.
19. Baker JR, Cardinal K, Bober C, Taylor MM and Samson WK: Neuropeptide W acts in brain to control prolactin, corticosterone, and growth hormone release. Endocrinology 144: 2816-2821, 2003.
20. Hochol A, Albertin G, Nussdorfer GG, Spinazzi R, Ziolkowska A, Rucinski M and Malendowicz LK: Effects of neuropeptide B and W on the secretion and growth of rat adrenocortical cells. Int J Mol Med 14: 843-847, 2004.
21. Hochol A, Belloni AS, Rucinski M, Ziolkowska A, Di Liddo R, Nussdorfer GG and Malendowicz LK: Expression of neuropeptides B and W and their receptors in endocrine glands of the rat. Int J Mol Med 18: 1101-1106, 2006.
22. Niimi M and Murao K: Neuropeptide W as a stress mediator in the hypothalamus. Endocrine 27: 51-54, 2005.
23. Andreis PG, Rucinski M, Neri G, Conconi MT, Petrelli L, Parnigotto PP, Malendowicz LK and Nussdorfer GG: Neuropeptides B and W enhance the growth of human adrenocortical carcinoma-derived NCI-H295 cells by exerting MAPK p42/p44-mediated proliferogenic and antiapoptotic effects. Int J Mol Med 16: 1021-1028, 2005.
24. Mazzocchi G, Rebuffat P, Ziolkowska A, Rossi GP, Malendowicz LK and Nussdorfer GG: G protein receptors 7 and 8 are expressed in human adrenocortical cells, and their endogenous ligands neuropeptides B and W enhance cortisol secretion by activating adenylate cyclase-and phospholipase C-dependent signaling cascades. J Clin Endocrinol Metab 90: 3466-3471, 2005.
25. Rucinski M, Nowak KW, Chmielewska J, Ziolkowska A and Malendowicz LK: Neuropeptide W exerts a potent suppressive effect on blood leptin and insulin concentrations in the rat. Int J Mol Med 19: 401-406, 2007.
26. Yu NS, Kunitake T, Kato K, Nakazato M and Kannan H: Effects of intracerebroventricular administration of neuropeptide W30 on neurons in the hypothalamic paraventricular nucleus in the conscious rat. Neurosci Lett 415: 140-145, 2007.
27. Seki M, Kageyama H, Takenoya F, Hirayama M, Kintaka Y, Inoue S, Matsuno R, Itabashi K, Date Y, Nakazato M and Shioda S: Neuropeptide W is expressed in the noradrenalin-containing cells in the rat adrenal medulla. Regul Pept 145: 147-152, 2008.
28. Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, McKee MD, Jung DY, Zhang Z, Kim JK, Mauvais-Jarvis F, Ducy P and Karsenty G: Endocrine regulation of energy metabolism by the skeleton. Cell 130: 456-469, 2007.
29. Dezaki K, Kageyama H, Seki M, Shioda S and Yada T: Neuropeptide W in the rat pancreas: Potentiation of glucose-induced insulin release and Ca(2+) influx through L-type Ca(2+) channels in beta-cells and localization in islets. Regul Pept 145: 153-158, 2008.
30. Boden SC, McCuaig K, Hair G, Racine M, Titus L, Wozney JM and Nanes MS: Differential effects and glucocorticoid potentiation of bone morphogenetic protein action during rat osteoblast differentiation in vitro. Endocrinology 137: 3401-3407, 1996.
31. Bodine PV and Komm BS: Tissue culture models for studies of hormone and vitamin action in bone cells. Vitam Horm 64: 101-151, 2002.
32. Kartsogiannis V and Ng KW: Cell lines and primary cell cultures in the study of bone cell biology. Mol Cell Endocrinol 228: 79-102, 2004.
33. Ziolkowska A, Rucinski M, Di Liddo R, Nussdorfer GG and Malendowicz LK: Expression of the beacon gene in endocrine glands of the rat. Peptides 25: 133-137, 2004.
34. Ziolkowska A, Carraro G, Rebuffat P, Spinazzi R, Nussdorfer GG, Rucinski M and Malendowicz LK: Beacon [47-73] inhibits glucocorticoid secretion and growth of cultured rat and human adrenocortical cells. Int J Mol Med 14: 457-461, 2004.
35. Ziolkowska A, Rucinski M, Pucher A, Tortorella C, Nussdorfer GG and Malendowicz LK: Expression of osteoblast marker genes in rat calvarial osteoblast-like cells, and effects of the endocrine disrupters diphenylolpropane, benzophenone-3, resveratrol and silymarin. Chem Biol Interact 164: 147-156, 2006.
36. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth 65: 55-63, 1983.
37. Albertin G, Carraro G, Parnigotto PP, Conconi MT, Ziolkowska A, Malendowicz LK and Nussdorfer GG: Human skin keratinocytes and fibroblasts express adrenomedullin and its receptors, and adrenomedullin enhances their growth in vitro by stimulating proliferation and inhibiting apoptosis. Int J Mol Med 11: 635-639, 2003.
38. Tortorella C, Macchi C, Spinazzi R, Malendowicz LK, Trejter M and Nussdorfer GG: Ghrelin, an endogenous ligand for the growth hormone-secretagogue receptor, is expressed in the human adrenal cortex. Int J Mol Med 12: 213-217, 2003.
39. Rucinski M, Andreis PG, Ziolkowska A, Nussdorfer GG and Malendowicz LK: Differential expression and function of beacon in the rat adrenal cortex and medulla. Int J Mol Med 16: 35-40, 2005.
40. Rucinski M, Ziolkowska A, Neri G, Trejter M, Zemleduch T, Tyczewska M, Nussdorfer GG and Malendowicz LK: Expression of neuromedins S and U and their receptors in the hypothalamus and endocrine glands of the rat. Int J Mol Med 20: 255-259, 2007.
41. Hochol A, Tortorella C, Rucinski M, Ziolkowska A, Nussdorfer GG and Malendowicz LK: Effects of neuropeptides B and W on the rat pituitary-adrenocortical axis: In vivo and in vitro studies. Int J Mol Med 19: 207-212, 2007.
42. Rodan GA and Noda M: Gene expression in osteoblastic cells. Crit Rev Eukaryot Gene Expr 1: 85-98, 1991.
43. Aubin JE, Liu F, Malaval L and Gupta AK: Osteoblast and chondroblast differentiation. Bone 17: 77-83, 1995.
44. Hinoi E, Fujimori S, Takemori A and Yoneda Y: Cell death by pyruvate deficiency in proliferative cultured calvarial osteoblasts. Biochem Biophys Res Commun 294: 1177-1183, 2002.
45. Sharma P, Solomon KR and Hauschka PV: High-throughput tool for discovery of bone regulating factors. Biotechniques 41: 539-542, 2006.
46. Malaval L, Liu F, Roche P and Aubin JE: Kinetics of osteoprogenitor proliferation and osteoblast differentiation in vitro. J Cell Biochem 74: 616-627, 1999.
47. Nakamura A, Dohi Y, Akahane M, Ohgushi H, Nakajima H, Funaoka H and Takakura Y: Osteocalcin secretion as an early marker of in vitro osteogenic differentiation of rat mesenchymal stem cells. Tissue Eng Part C Methods 15: 169-180, 2009.
48. Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM and Karsenty G: Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100: 197-207, 2000.
49. Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL, Armstrong D, Ducy P and Karsenty G: Leptin regulates bone formation via the sympathetic nervous system. Cell 111: 305-317, 2002.
50. Cornish J, Callon KE, Bava U, Lin C, Naot D, Hill BL, Grey AB, Broom N, Myers DE, Nicholson GC and Reid IR: Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J Endocrinol 175: 405-415, 2002.
51. Gordeladze JO and Reseland JE: A unified model for the action of leptin on bone turnover. J Cell Biochem 88: 706-712, 2003.
52. Thomas T: The complex effects of leptin on bone metabolism through multiple pathways. Curr Opin Pharmacol 4: 295-300, 2004.
53. Hamrick MW, Della-Fera MA, Choi YH, Pennington C, Hartzell D and Baile CA: Leptin treatment induces loss of bone marrow adipocytes and increases bone formation in leptin-deficient ob/ob mice. J Bone Miner Res 20: 994-1001, 2005.
54. Karsenty G: Convergence between bone and energy homeostases: leptin regulation of bone mass. Cell Metab 4: 341-348, 2006.
55. Sato S, Hanada R, Kimura A, Abe T, Matsumoto T, Iwasaki M, Inose H, Ida T, Mieda M, Takeuchi Y, Fukumoto S, Fujita T, Kato S, Kangawa K, Kojima M, Shinomiya K and Takeda S: Central control of bone remodeling by neuromedin U. Nat Med 13: 1234-1240, 2007.
56. Kelly MA, Beuckmann CT, Williams SC, Sinton CM, Motoike T, Richardson JA, Hammer RE, Garry MG and Yanagisawa M: Neuropeptide B-deficient mice demonstrate hyperalgesia in response to inflammatory pain. Proc Natl Acad Sci USA 102: 9942-9927, 2005.